Hasil Pencarian - P. Grivas

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guérin (BCG)

    Updated follow-up from KEYNOTE-057: Phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non–muscle invasive bladder cancer (NMIBC) unresponsive to bacill... oleh J.L. Boormans, R. De Wit, G.S. Kulkarni, E.M. Uchio, M. Roumiguié, L.E.M. Krieger, E.A. Singer, D.F. Bajorin, A.M. Kamat, P. Grivas, H.K. Seo, H. Nishiyama, B.R. Konethy, T. Saretsky, H. Li, K. Nam, E. Kapadia, A.V. Balar

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Contrasting genomic profiles in post-systemic treatment metastatic sites (MET) and pre-treatment primary tumors (PT) of clinically advanced prostate cancer (PC)

    Contrasting genomic profiles in post-systemic treatment metastatic sites (MET) and pre-treatment primary tumors (PT) of clinically advanced prostate cancer (PC) oleh A. Necchi, P. Grivas, G. Bratslavsky, O. Shapiro, J. Jacob, E. Sokol, J. Vergilio, J. Killian, D. Lin, J. Haberberger, J. Tse, S. Ramkissoon, E. Severson, A. Hemmerich, R. Huang, S. Ali, J. Chung, R. Madison, B. Alexander, P. Reddy, J. Elvin, A. Schrock, N. Danziger, J. Ross

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)

    Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS) oleh P. Grivas, Y. Loriot, R. Morales-Barrera, M. Y. Teo, Y. Zakharia, S. Feyerabend, N. J. Vogelzang, E. Grande, N. Adra, A. Alva, A. Necchi, A. Rodriguez-Vida, S. Gupta, D. H. Josephs, S. Srinivas, K. Wride, D. Thomas, A. Simmons, A. Loehr, R. L. Dusek, D. Nepert, S. Chowdhury

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter cohort study

    Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: results from a large multicenter coh... oleh F. Soria, A. Giordano, P. Black, A. Fairey, M. Cookson, E. Yu, W. Kassouf, M. Dall’Era, S. Sridhar, J. McGrath, J. Wright, A. Thorpe, T. Morgan, S. Daneshmand, J. Holzbeierlein, T. Bivalacqua, S. North, D. Barocas, Y. Lotan, P. Grivas, A. Stephenson, J. Shah, B. van Rhijn, P. Spiess, S. Shariat, P. Gontero

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: Results of an international consortium

    Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: Results of an international consorti... oleh M. Marchioni, M.C. Mir, H. Zargar, P. Grivas, M.A.D. Dall’era, P.E.S. Spiess, B.W. Van Rhijn, Y. Lotan, T.J. Bivalacqua, J.M. Holzbeierlein, A. Thorpe, E. Yu, S.F. Shariat, W. Kassouf, D.A. Barocas, S. Daneshmand, C.P. Dinney, J.S. Mcgrath, S.S. Sridhar, J. Wright, S. North, A.J Stephenson, E. Xylinas, P. Black

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: Results from a large multicenter cohort study

    Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer patients without hydronephrosis: Results from a large multicenter coh... oleh F. Soria, P.C. Black, A.S. Fairey, M.S. Cookson, E.Y. Yu, W. Kassouf, M.A. Dall’era, S.S. Sridhar, J.S. Mcgrath, J.L. Wright, A.C. Thorpe, T.M. Morgan, S. Daneshmand, J.M. Holzbeierlein, T.J. Bivalacqua, S. North, D.A. Barocas, Y. Lotan, P. Grivas, A.J. Stephenson, J.B. Shah, B.W. Van Rhijn, P.E. Spiess, S.F. Shariat, P. Gontero

    Diterbitkan 2020-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium

    Nomogram predicting bladder cancer specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consorti... oleh C. Mir, M. Marchioni, H. Zargar, K. Zargar-Shoshtari, A.S. Fairey, L.S. Mertens, C.P. Dinney, L. Krabbe, M.S. Cookson, N. Jacobsen, J. Griffin, J.S. Montgomery, N. Vasdev, E.Y. Yu, E. Xylinas, J.S. McGrath, W. Kassouf, M.A. Dell’Era, S.S. Sridhar, J. Aning, S.F. Shariat, J.L. Wright, A.C. Thorpe, T.M. Morgan, J.M. Holzbeierlein, T.J. Bivalacqua, S. North, D.A. Barocas, Y. Lotan, P. Grivas, A.J. Stephenson, J.B. Shah, B.W. van Rhijn, P.E. Spiess, S. Daneshmand, P.C. Black

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: